Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Clinical Outcomes and Costs Following Unplanned Excisions of Soft Tissue Sarcomas in the Elderly.

Bateni SB, Gingrich AA, Jeon SY, Hoch JS, Thorpe SW, Kirane AR, Bold RJ, Canter RJ.

J Surg Res. 2019 Feb 27;239:125-135. doi: 10.1016/j.jss.2019.01.055. [Epub ahead of print]

PMID:
30825757
2.

Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis.

Bateni SB, Davidson AJ, Arora M, Daly ME, Stewart SL, Bold RJ, Canter RJ, Sauder CAM.

Ann Surg Oncol. 2019 Feb 13. doi: 10.1245/s10434-019-07159-4. [Epub ahead of print]

PMID:
30761438
3.

Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.

Raut CP, Callegaro D, Miceli R, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Nessim C, Swallow CJ, Bagaria S, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Fiore M, Fairweather M, Gronchi A.

Clin Cancer Res. 2019 Feb 5. doi: 10.1158/1078-0432.CCR-18-2700. [Epub ahead of print]

PMID:
30723141
4.

Metastatic Immune Infiltrates Correlate with Those of the Primary Tumor in Canine Osteosarcoma.

Withers SS, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Burton JH, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB.

Vet Comp Oncol. 2019 Jan 25. doi: 10.1111/vco.12459. [Epub ahead of print]

PMID:
30684301
5.

Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells.

Luna JI, Grossenbacher SK, Sturgill IR, Ames E, Judge SJ, Bouzid LA, Darrow MA, Murphy WJ, Canter RJ.

Cancers (Basel). 2019 Jan 14;11(1). pii: E85. doi: 10.3390/cancers11010085.

6.

Survival benefits associated with surgery for advanced non-small cell lung cancer.

David EA, Andersen SW, Beckett LA, Melnikow J, Clark JM, Brown LM, Cooke DT, Kelly K, Canter RJ.

J Thorac Cardiovasc Surg. 2018 Nov 14. pii: S0022-5223(18)32941-6. doi: 10.1016/j.jtcvs.2018.10.140. [Epub ahead of print]

PMID:
30551965
7.

Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management.

Bateni SB, Gingrich AA, Stewart SL, Meyers FJ, Bold RJ, Canter RJ.

BMC Cancer. 2018 Nov 26;18(1):1166. doi: 10.1186/s12885-018-5108-9.

8.

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.

Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O'Connor DJ, Méndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM.

Nat Med. 2019 Jan;25(1):141-151. doi: 10.1038/s41591-018-0221-5. Epub 2018 Nov 12.

PMID:
30420753
9.

Restricted fluid bolus versus current practice in children with septic shock: the FiSh feasibility study and pilot RCT.

Inwald D, Canter RR, Woolfall K, O'Hara CB, Mouncey PR, Zenasni Z, Hudson N, Saunders S, Carter A, Jones N, Lyttle MD, Nadel S, Peters MJ, Harrison DA, Rowan KM.

Health Technol Assess. 2018 Sep;22(51):1-106. doi: 10.3310/hta22510.

10.

Drivers of Cost for Pancreatic Surgery: It's Not About Hospital Volume.

Bateni SB, Olson JL, Hoch JS, Canter RJ, Bold RJ.

Ann Surg Oncol. 2018 Dec;25(13):3804-3811. doi: 10.1245/s10434-018-6758-1. Epub 2018 Sep 14.

PMID:
30218244
11.

Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma.

Withers SS, Skorupski KA, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Rodriguez CO, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB.

Vet Comp Oncol. 2019 Mar;17(1):49-60. doi: 10.1111/vco.12444. Epub 2018 Sep 19.

PMID:
30156029
12.

Restricted fluid bolus volume in early septic shock: results of the Fluids in Shock pilot trial.

Inwald DP, Canter R, Woolfall K, Mouncey P, Zenasni Z, O'Hara C, Carter A, Jones N, Lyttle MD, Nadel S, Peters MJ, Harrison DA, Rowan KM; PERUKI (Paediatric Emergency Research in the UK and Ireland) and PICS SG (Paediatric Intensive Care Society Study Group).

Arch Dis Child. 2018 Aug 7. pii: archdischild-2018-314924. doi: 10.1136/archdischild-2018-314924. [Epub ahead of print]

13.
14.

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia-telangiectasia.

Judge SJ, Plescia TA, Bateni CP, Darrow MA, Evans CP, Canter RJ.

Rare Tumors. 2018 Jul 22;10:2036361318789724. doi: 10.1177/2036361318789724. eCollection 2018.

15.

Author Correction: Gamma frequency entrainment attenuates amyloid load and modifies microglia.

Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, Mathys H, Seo J, Kritskiy O, Abdurrob F, Adaikkan C, Canter RG, Rueda R, Brown EN, Boyden ES, Tsai LH.

Nature. 2018 Oct;562(7725):E1. doi: 10.1038/s41586-018-0351-4.

PMID:
30046102
16.

Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site.

McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1259-1270. doi: 10.1016/j.ijrobp.2018.04.038. Epub 2018 Apr 22.

PMID:
29891204
17.

FIRST-line support for Assistance in Breathing in Children (FIRST-ABC): a multicentre pilot randomised controlled trial of high-flow nasal cannula therapy versus continuous positive airway pressure in paediatric critical care.

Ramnarayan P, Lister P, Dominguez T, Habibi P, Edmonds N, Canter RR, Wulff J, Harrison DA, Mouncey PM, Peters MJ; United Kingdom Paediatric Intensive Care Society Study Group (PICS-SG).

Crit Care. 2018 Jun 4;22(1):144. doi: 10.1186/s13054-018-2080-3.

18.

Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs.

Withers SS, Moore PF, Chang H, Choi JW, McSorley SJ, Kent MS, Monjazeb AM, Canter RJ, Murphy WJ, Sparger EE, Rebhun RB.

Dev Comp Immunol. 2018 Oct;87:64-74. doi: 10.1016/j.dci.2018.05.022. Epub 2018 May 31.

PMID:
29859828
19.

Obesity as an immune-modifying factor in cancer immunotherapy.

Canter RJ, Le CT, Beerthuijzen JMT, Murphy WJ.

J Leukoc Biol. 2018 Sep;104(3):487-497. doi: 10.1002/JLB.5RI1017-401RR. Epub 2018 May 15. Review.

PMID:
29762866
20.

Skeletal Muscle Metrics on Clinical 18F-FDG PET/CT Predict Health Outcomes in Patients with Sarcoma.

Foster B, Boutin RD, Lenchik L, Gedeon D, Liu Y, Nittur V, Badawi RD, Li CS, Canter RJ, Chaudhari AJ.

J Nat Sci. 2018;4(5). pii: e502.

21.

Palliative Care Training and Decision-Making for Patients with Advanced Cancer: A Comparison of Surgeons and Medical Physicians.

Bateni SB, Canter RJ, Meyers FJ, Galante JM, Bold RJ.

Surgery. 2018 Apr 27. pii: S0039-6060(18)30078-3. doi: 10.1016/j.surg.2018.01.021. [Epub ahead of print]

PMID:
29709369
22.

Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma.

Yanagisawa M, Gingrich AA, Judge S, Li CS, Wang N, Thorpe SW, Kirane AR, Bold RJ, Monjazeb AM, Canter RJ.

Anticancer Res. 2018 Mar;38(3):1491-1497.

23.

Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy.

Spiller KJ, Restrepo CR, Khan T, Dominique MA, Fang TC, Canter RG, Roberts CJ, Miller KR, Ransohoff RM, Trojanowski JQ, Lee VM.

Nat Neurosci. 2018 Mar;21(3):329-340. doi: 10.1038/s41593-018-0083-7. Epub 2018 Feb 20.

24.

Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma.

Tseng WW, Tsao-Wei DD, Callegaro D, Grignani G, D'Ambrosio L, Bonvalot S, Ethun CG, Cardona K, Mullen JT, Canter RJ, Mullinax JE, Gonzalez RJ, van Coevorden F, Albertsmeier M, Dhanireddy KK, Renne SL, Gronchi A; A Collaborative Effort from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG).

Eur J Surg Oncol. 2018 Jun;44(6):810-815. doi: 10.1016/j.ejso.2018.01.086. Epub 2018 Feb 5.

PMID:
29452860
25.

Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas.

Henderson T, Chen M, Darrow MA, Li CS, Chiu CL, Monjazeb AM, Murphy WJ, Canter RJ.

J Surg Res. 2018 Mar;223:207-214. doi: 10.1016/j.jss.2017.11.016. Epub 2017 Dec 22.

26.

Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.

Canter RJ, Grossenbacher SK, Foltz JA, Sturgill IR, Park JS, Luna JI, Kent MS, Culp WTN, Chen M, Modiano JF, Monjazeb AM, Lee DA, Murphy WJ.

J Immunother Cancer. 2017 Dec 19;5(1):98. doi: 10.1186/s40425-017-0305-7.

27.

Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy.

Zaidi MY, Canter R, Cardona K.

J Surg Oncol. 2018 Jan;117(1):99-104. doi: 10.1002/jso.24927. Epub 2017 Nov 28. Review.

PMID:
29193081
28.

Comparison of common risk stratification indices to predict outcomes among stage IV cancer patients with bowel obstruction undergoing surgery.

Bateni SB, Bold RJ, Meyers FJ, Canter DJ, Canter RJ.

J Surg Oncol. 2018 Mar;117(3):479-487. doi: 10.1002/jso.24866. Epub 2017 Oct 16.

29.

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients.

David EA, Andersen SW, Beckett LA, Melnikow J, Kelly K, Cooke DT, Brown LM, Canter RJ.

Ann Thorac Surg. 2017 Nov;104(5):1665-1672. doi: 10.1016/j.athoracsur.2017.05.071. Epub 2017 Sep 28.

30.

Reply.

David EA, Canter RJ.

Ann Thorac Surg. 2017 Oct;104(4):1437-1438. doi: 10.1016/j.athoracsur.2017.03.052. No abstract available.

PMID:
28935316
31.

A qualitative feasibility study to inform a randomised controlled trial of fluid bolus therapy in septic shock.

O'Hara CB, Canter RR, Mouncey PR, Carter A, Jones N, Nadel S, Peters MJ, Lyttle MD, Harrison DA, Rowan KM, Inwald D, Woolfall K.

Arch Dis Child. 2018 Jan;103(1):28-32. doi: 10.1136/archdischild-2016-312515. Epub 2017 Aug 28.

32.

The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer.

David EA, Clark JM, Cooke DT, Melnikow J, Kelly K, Canter RJ.

J Thorac Oncol. 2017 Nov;12(11):1636-1645. doi: 10.1016/j.jtho.2017.08.008. Epub 2017 Aug 24. Review.

33.

Response to "Reframing the Concept of 'No Treatment' in Advanced NSCLC".

David EA, Canter RJ.

J Thorac Oncol. 2017 Aug;12(8):e126-e127. doi: 10.1016/j.jtho.2017.05.007. No abstract available.

34.

Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis.

Gingrich AA, Bateni SB, Monjazeb AM, Darrow MA, Thorpe SW, Kirane AR, Bold RJ, Canter RJ.

Ann Surg Oncol. 2017 Oct;24(11):3252-3263. doi: 10.1245/s10434-017-6019-8. Epub 2017 Jul 24.

35.

FIRST-line support for Assistance in Breathing in Children (FIRST-ABC): protocol for a multicentre randomised feasibility trial of non-invasive respiratory support in critically ill children.

Ramnarayan P, Lister P, Dominguez T, Habibi P, Edmonds N, Canter R, Mouncey P, Peters MJ.

BMJ Open. 2017 Jun 12;7(6):e016181. doi: 10.1136/bmjopen-2017-016181.

36.

The modified frailty index to predict morbidity and mortality for retroperitoneal sarcoma resections.

Park JS, Bateni SB, Bold RJ, Kirane AR, Canter DJ, Canter RJ.

J Surg Res. 2017 Sep;217:191-197. doi: 10.1016/j.jss.2017.05.025. Epub 2017 May 11.

37.

Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis.

PRISM Investigators, Rowan KM, Angus DC, Bailey M, Barnato AE, Bellomo R, Canter RR, Coats TJ, Delaney A, Gimbel E, Grieve RD, Harrison DA, Higgins AM, Howe B, Huang DT, Kellum JA, Mouncey PR, Music E, Peake SL, Pike F, Reade MC, Sadique MZ, Singer M, Yealy DM.

N Engl J Med. 2017 Jun 8;376(23):2223-2234. doi: 10.1056/NEJMoa1701380. Epub 2017 Mar 21.

38.

Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis.

David EA, Daly ME, Li CS, Chiu CL, Cooke DT, Brown LM, Melnikow J, Kelly K, Canter RJ.

J Thorac Oncol. 2017 Mar;12(3):437-445. doi: 10.1016/j.jtho.2016.11.2221. Epub 2017 Jan 18.

39.

Canine cancer immunotherapy studies: linking mouse and human.

Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WTN, Sparger EE, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ.

J Immunother Cancer. 2016 Dec 20;4:97. doi: 10.1186/s40425-016-0200-7. eCollection 2016. Review.

40.

Lung resection is safe and feasible among stage IV cancer patients: An American College of Surgeons National Surgical Quality Improvement Program analysis.

Bateni SB, David EA, Bold RJ, Cooke DT, Meyers FJ, Canter RJ.

Surgery. 2017 May;161(5):1307-1314. doi: 10.1016/j.surg.2016.11.002. Epub 2016 Dec 20.

PMID:
28011006
41.

Predictors of residual disease after unplanned excision of soft tissue sarcomas.

Gingrich AA, Elias A, Michael Lee CY, Nakache YN, Li CS, Shah DR, Boutin RD, Canter RJ.

J Surg Res. 2017 Feb;208:26-32. doi: 10.1016/j.jss.2016.08.096. Epub 2016 Sep 8.

42.

Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.

Luna JI, Grossenbacher SK, Murphy WJ, Canter RJ.

Expert Opin Biol Ther. 2017 Mar;17(3):313-324. doi: 10.1080/14712598.2017.1271874. Epub 2016 Dec 23. Review.

43.

Gamma frequency entrainment attenuates amyloid load and modifies microglia.

Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, Mathys H, Seo J, Kritskiy O, Abdurrob F, Adaikkan C, Canter RG, Rueda R, Brown EN, Boyden ES, Tsai LH.

Nature. 2016 Dec 7;540(7632):230-235. doi: 10.1038/nature20587. Erratum in: Nature. 2018 Oct;562(7725):E1.

44.

The road to restoring neural circuits for the treatment of Alzheimer's disease.

Canter RG, Penney J, Tsai LH.

Nature. 2016 Nov 10;539(7628):187-196. doi: 10.1038/nature20412. Review.

PMID:
27830780
45.

National survey and point prevalence study of sedation practice in UK critical care.

Richards-Belle A, Canter RR, Power GS, Robinson EJ, Reschreiter H, Wunsch H, Harvey SE.

Crit Care. 2016 Oct 27;20(1):355.

46.

Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical Practice.

Bateni SB, Meyers FJ, Bold RJ, Canter RJ.

PLoS One. 2016 Oct 25;11(10):e0165315. doi: 10.1371/journal.pone.0165315. eCollection 2016.

47.

Conservative management of desmoid tumors is safe and effective.

Park JS, Nakache YP, Katz J, Boutin RD, Steffner RJ, Monjazeb AM, Canter RJ.

J Surg Res. 2016 Sep;205(1):115-20. doi: 10.1016/j.jss.2016.06.028. Epub 2016 Jun 16.

PMID:
27621007
48.

Chemotherapy: Does Neoadjuvant or Adjuvant Therapy Improve Outcomes?

Canter RJ.

Surg Oncol Clin N Am. 2016 Oct;25(4):861-72. doi: 10.1016/j.soc.2016.05.013. Epub 2016 Aug 5. Review.

PMID:
27591503
49.

Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?

David EA, Cooke DT, Chen Y, Nijar K, Canter RJ, Cress RD.

Ann Thorac Surg. 2017 Jan;103(1):226-235. doi: 10.1016/j.athoracsur.2016.05.018. Epub 2016 Jul 26.

PMID:
27469339
50.

Delayed phlegmon with gallstone fragments masquerading as soft tissue sarcoma.

Goodman LF, Bateni CP, Bishop JW, Canter RJ.

J Surg Case Rep. 2016 Jun 22;2016(6). pii: rjw106. doi: 10.1093/jscr/rjw106.

Supplemental Content

Loading ...
Support Center